| Serial Number | 97787004 |
| Word Mark | C CELLPOINT |
| Filing Date | Wednesday, February 8, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 10, 2024 |
| Registration Number | 7498517 |
| Registration Date | Tuesday, September 10, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 25, 2024 |
| Goods and Services | Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals |
| Description of Mark | The mark consists of a red dot to the left of the letter "C" outlined in a blue and green background, to the left of the word "CELLPOINT" in stylized blue font. |
| Goods and Services | Pharmaceutical substances and preparations for human use, namely, pharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human use, namely, biopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use |
| Pseudo Mark | C CELL POINT |
| Indication of Colors claimed | The color(s) blue, red, and green is/are claimed as a feature of the mark. |
| Goods and Services | Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical services, namely, Stemcell and celltherapy services; Medical services relating to the removal, treatment and processing of human cells |
| Goods and Services | Medical, scientific and industrial research services in the field of pharmaceuticals, engineered patient T-cells, cell therapy, and gene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression, namely, analysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; development, examination, namely, quality control, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocols, computer software for testing, reagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Galapagos NV |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Mechelen 2800 BE |
| Party Name | Galapagos NV |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Mechelen 2800 BE |
| Party Name | Galapagos NV |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mechelen 2800 BE |
| Event Date | Event Description |
| Saturday, February 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, February 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 1, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 21, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 25, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, August 25, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, August 25, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, September 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 6, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2024 | ASSIGNED TO LIE |
| Wednesday, February 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 16, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, June 5, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 25, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 25, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 10, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 10, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |